Detalhe da pesquisa
1.
Development of in vitro models to demonstrate the ability of PecSys®, an in situ nasal gelling technology, to reduce nasal run-off and drip.
Drug Dev Ind Pharm
; 39(5): 816-24, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22803832